Strategies helps businesses and individuals solve the complexities of dealing with the government at every level. Our team of specialists concentrate exclusively on government affairs, representing clients nationwide who need assistance with public policy, advocacy, and government relations strategies.
This unique program provides innovative and affordable opportunities to startups and early-stage emerging companies with a solid technology or scientific foundation. We help companies that have a quality management team in place and do not have other significant legal representation.
eMerge’s lawyers and technologists work together to deliver strategic end-to-end eDiscovery and data management solutions for litigation, investigations, due diligence, and compliance matters. We help clients discover the information necessary to resolve disputes, respond to investigations, conduct due diligence, and comply with legal requirements.
BOSTON – Troutman Pepper Locke advised Eupraxia Pharmaceuticals, Inc. (Eupraxia) (NASDAQ: EPRX; TSX: EPRX), a clinical-stage biotechnology company developing targeted therapies that leverage a proprietary extended-release delivery system to provide the right dose of a drug, in its public offering of 14,636,363 common shares at $5.50 per common share for gross proceeds of approximately $80.5 million, before deducting the underwriting commissions and estimated expenses incurred in connection with the offering. For more information, see the press release.
Eupraxia intends to use the net proceeds from the offering primarily for the continued advancement of its product pipeline, including the completion of ongoing preclinical studies and clinical trials, regulatory submissions, and associated commercial preparation and manufacturing scale-up activities.
The Troutman Pepper Locke team that advised Eupraxia was led by Tom Rose, Shona Smith, Nicole Edmonds, Alex Yarbrough, Jason Langford, Taylor Williams, and Joe Cataldo, and included Mark Goldsmith, Noreen Onimus, Heather Morehouse Ettinger, and Judy O’Grady.
Consistently recognized as a top-tier practice, Troutman Pepper Locke’s corporate attorneys regularly handle strategic deals for clients ranging from industry leading, Fortune 100 corporations to emerging companies. Core areas of service include mergers and acquisitions, corporate finance, corporate governance, securities laws compliance, capital markets transactions, and other significant domestic and cross-border transactions, as well as general corporate counseling.
Troutman Pepper Locke
Troutman Pepper Locke helps clients solve complex legal challenges and achieve their business goals in an ever-changing global economy. With more than 1,600 attorneys in 30+ offices, the firm serves clients in all major industry sectors, with particular depth in energy, financial services, health care and life sciences, insurance and reinsurance, private equity, and real estate. Learn more at troutman.com.
Speaking Engagements
Governmental Hospitals In Bankruptcy: An Immovable Object Meets An Irresistible Force
April 17, 2026 | 4:00 PM – 5:00 PM ET
Hilton Atlanta
255 Courtland Street NE, Atlanta, GA 30303
Speaking Engagements
2026 ACA Conference
April 17, 2026 | 8:30 AM – 9:15 AM CT
Omni Nashville Hotel
250 Rep. John Lewis Way South, Nashville, TN 37203
Speaking Engagements
myLawCLE | College Athletes as Enterprise: NIL Deals, Revenue Sharing, and Post-House NCAA Enforcement
April 16, 2026 | 1:00 PM – 4:05 PM ET
Open for Registration Online
Speaking Engagements
26th IBA/ABA Annual US and Europe Tax Practice Trends Conference: “Emerging Company Tax Issues” Panel
April 16, 2026 | 11:30 AM – 1:00 PM
The Westin Excelsior
Rome, Italy
